BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32570839)

  • 1. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
    Hubmann R; Schnabl S; Araghi M; Schmidl C; Rendeiro AF; Hilgarth M; Demirtas D; Ali F; Staber PB; Valent P; Zielinski C; Jäger U; Shehata M
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells.
    Hubmann R; Hilgarth M; Schnabl S; Ponath E; Reiter M; Demirtas D; Sieghart W; Valent P; Zielinski C; Jäger U; Shehata M
    Br J Haematol; 2013 Mar; 160(5):618-29. PubMed ID: 23278106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2.
    Duechler M; Shehata M; Schwarzmeier JD; Hoelbl A; Hilgarth M; Hubmann R
    Leukemia; 2005 Feb; 19(2):260-7. PubMed ID: 15565166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
    Rosati E; Sabatini R; De Falco F; Del Papa B; Falzetti F; Di Ianni M; Cavalli L; Fettucciari K; Bartoli A; Screpanti I; Marconi P
    Int J Cancer; 2013 Apr; 132(8):1940-53. PubMed ID: 23001755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.
    Hubmann R; Düchler M; Schnabl S; Hilgarth M; Demirtas D; Mitteregger D; Hölbl A; Vanura K; Le T; Look T; Schwarzmeier JD; Valent P; Jäger U; Shehata M
    Br J Haematol; 2010 Mar; 148(6):868-78. PubMed ID: 19995395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
    Rosati E; Sabatini R; Rampino G; Tabilio A; Di Ianni M; Fettucciari K; Bartoli A; Coaccioli S; Screpanti I; Marconi P
    Blood; 2009 Jan; 113(4):856-65. PubMed ID: 18796623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
    Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
    Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
    Hubmann R; Schwarzmeier JD; Shehata M; Hilgarth M; Duechler M; Dettke M; Berger R
    Blood; 2002 May; 99(10):3742-7. PubMed ID: 11986231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.
    Wang D; Xu J; Liu B; He X; Zhou L; Hu X; Qiao F; Zhang A; Xu X; Zhang H; Wicha MS; Zhang L; Shao ZM; Liu S
    Cell Death Differ; 2018 Feb; 25(2):330-339. PubMed ID: 29027990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch Signaling Participates in TGF-β-Induced SOST Expression Under Intermittent Compressive Stress.
    Manokawinchoke J; Sumrejkanchanakij P; Pavasant P; Osathanon T
    J Cell Physiol; 2017 Aug; 232(8):2221-2230. PubMed ID: 27966788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients.
    Fatima K; Paracha RZ; Qadri I
    Mol Biol Rep; 2012 May; 39(5):5059-67. PubMed ID: 22161246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
    De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
    Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.
    Shukla V; Shukla A; Joshi SS; Lu R
    Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells.
    Baeten JT; Lilly B
    J Biol Chem; 2015 Jun; 290(26):16226-37. PubMed ID: 25957400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
    Wang L; Dai G; Yang J; Wu W; Zhang W
    Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
    De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
    Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
    Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
    Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases.
    Yang X; Zhang Y; Huang Y; Wang Y; Qi X; Su T; Lu L
    Phytomedicine; 2020 Mar; 68():153176. PubMed ID: 32045841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC.
    Frank SB; Berger PL; Ljungman M; Miranti CK
    J Cell Sci; 2017 Jun; 130(11):1952-1964. PubMed ID: 28446540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.